Summary.-Electron spin resonance studies have been made of caeruloplasmin and iron transferrin levels in whole blood of healthy controls and patients with a variety of malignant conditions receiving various forms of treatment.
VARIATIONS in serum concentrations of Cu, caeruloplasmin and Fe have been reported to be associated with a variety of conditions, e.g. increases in serum Cu were associated with administration of oestrogens (Russ and Raymunt, 1956) Cu level rose and Fe fell in serum of postoperative patients (Zwicker, 1959) and serum Cu fell after exposure to ionizing radiations (Tomas, Cristea and Mocanu, 1972 ), as did plasma Fe level (O'Shea, Kershenobich and Tavill, 1973) . Serum Cu rose with inflammation and acute and chronic infections (Brendstrup, 1953) . Such changes must be considerecl in any assessment of the clinical value of measurements of blood caeruloplasmin and Fe transferrin level. Hughes (1 972), using radial immunodiffusion, found an increase in mean serum caeruloplasmin and a decrease in mean transferrin (as opposed to Fe transferrin) concentrations in patients with malignant disease. A study of electron spin resonanace (ESR) signals from caeruloplasmin by Swartz and Wiesner (I1972) showed an increase in signal size in mixed cancer patients, and a decrease on response to radiotherapy. Foster et al. (1973) showed that caeruloplasmin (g 2.049) and Fe transferrin (g , 4.2) levels can be measured by ESR in whole, frozen blood and that a small increase in mean size of caeruloplasmin signal can be detected in patients suffering from malignant diseases as compared with healthy controls. A larger-scale investigation of malignant lymphoma (Foster et al., 1 977a, b) has shown that the already-known variations in serum Cu with disease activity in Hodgkin's disease can be detected by ESR and that these are much less marked in non-Hodgkin's lymphoma. Also the ESR-detectable changes in Hodgkin's disease occurred well before relapse was clinically detectable.
A further study of changes in caeruloplasmin and Fe transferrin levels in other malignant diseases has now been made, particularly attempting to analyse extraneous factors that might influence the results, and hence to isolate any variations which may be due specifically to the diseases. Also, to provide a basis for comparison with these results, a survey has been made of ESR signals in blood of healthy controls under various conditions.
MATERIALS AND TECHNIQUES
Techniques used for the ESR study of caeruloplasmin and Fe transferrin in whole blood are identical to those previously described (Foster et al., 1977a 
Normal subjects
The range of peak-to-peak heights for the caeruloplasmin (g 2.049) signal in males, and in females receiving or not receiving contraceptive steroids, is shown in Fig. 1 . The difference between males and normal females is small but significant (P>0.01) and females receiving contraceptive steroids showed a considerable increase in mean caeruloplasmin level. The wider scatter in normal females than in males may have been due to some women stating that they were not receiving contraceptives when, in fact, they were. The scatter in steroid female results may be due to the variation in oestradiol dose between different preparations. Factors affecting basic level Blood from patients with malignant diseases was examined to see whether factors other than malignancy were affecting caeruloplasmin and Fe transferrin levels. Several treatments, including surgery and chemo-and radio-therapy, were used and analysis of the effects of individual treatments was complicated by the use of two or more therapies, often at the same time on the same patient.
Sampling was only possible on certain days of the week, and hence synchronizing from sufficient numbers of to obtain a mean value was not always possible. For this reason many of the data cannot be pooled and hence, for some factors, only general conclusions can be offered.
Nineteen patients were treated surgically before any other treatment, and therefore were suitable for studying the effects of surgery. Fig. 3 shows the change, by expressing the signal heights as a percentage of the level measured in the 3 days before treatment. In 5 cases the caeruloplasmin signal was measured a week before this "pre-surgical" sample. The range in these 5 samples was 84 to 124% with a mean of 101% compared to the appropriate "pre-surgical" sample. Occasional high values are seen in the pretreatment groups, but these are rare, only 8/51 samples having a signal height above 1*75 (the approximate upper limit of normal) whilst in the post-treatment group, 9/24 samples were higher than 1 75. A slight decrease in mean Fe transferrin was observed, and in this case the effect was more marked in samples from patients with squamous-cell carcinoma than with breast cancer. Once again there is no significant difference between pre-and post-treatment samples. From the data so far accumulated, an upper limit of 1P75 for peak-to-peak height of caeruloplasmin signal is normal in controls. This would correspond to a level of 46 mg of caeruloplasmin per 100 ml of plasma, which is in the upper region of normal. Average level in plasma is quoted as 30 mg/100 ml (Miale, 1967) , A solution of purified human caeruloplasmin in saline at a concentration of 15 mg/I 00 ml yields a peak-to-peak height of I 12. The values of 1 10 for males and 1 25 for non-steroid females for whole blood are, therefore, in the expected range. The lack of difference in Fe transferrin levels between the sexes also confirms previous suggestions (e.g. Miale, 1967) .
The study of the various factors apart from malignant disease, which might affect basic Cu and Fe levels, showed that many patients might be expected to have abnormal amounts of paramagnetic metals in the blood. Most studies in the past have been made using a general batch of patients who were unsorted as regards the type of treatment they were receiving. This is true of the preliminary report of this team (Foster et al., 1973) where elevations in caeruloplasmin signal were found in patients with breast cancer when considered as an unsorted group. The present study shows that, if only those patients who are not receiving treatment are considered, this elevation, although still present, is very small. Many breast cancer patients are treated surgically, and it is possible that by including such patients in the sample, abnormally high mean values can be obtained for caeruloplasmin level.
